Acetylsalicylic acid Withdrawn Phase 3 Trials for Aspirin / Survival / Lung Cancer Non-Small Cell Cancer (NSCLC) Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Withdrawn | Treatment | 3 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT01058902 | The Effect Of Aspirin On Survival in Lung Cancer |